2020 -
2023 Independent Consultant and Entrepreneur @ 自僱
2017 -
2020 Investigator III at Exploratory Immuno-Oncology @
2016 -
2017 Investigator II at Exploratory Immuno-Oncology @
2016 -
2016 Principal Scientist at Cell and Gene Therapy @
2014 -
2016 Senior Scientist at Cell and Gene Therapy @
2011 -
2014 Postdoc Research Fellow @
2010 -
2011 Postdoctoral Fellow @ Genomic Research Center
2002 -
2007 Reasearch Scientist @ Academia Sinica
Ming-Wei Chen Education
Rockefeller University
Postdoc
2010
-
2014
National Yang Ming University
Doctor of Philosophy (Ph.D.)
2007
-
2010
National Chung Hsing University
Master of Science (MS)
2000
-
2002
Ming-Wei Chen Skills
Gene Therapy
Molecular Biology
Biochemistry
Vaccines
Gene Transfer
Vector Design
Antibodies
Influenza
HIV
FRET
Cell Biology
Mouse Handling
Gene Expression
Genetic Engineering
RNA biology
recombinant DNA technology
Glycobiology
Virology
Immunology
Epigenetics
ChIP
Gene editing
genome engineering
Molecular & Cellular Biology
Cancer Immunotherapy
Process Optimization
Lc Ms
Leadership
Science
Protein Chemistry
Chromatography
Molecular and Cellular Biology
Functional Analysis
Military
Method Development
Biophysical Chemistry
Ming-Wei Chen Summary
Ming-Wei Chen, based in Boston, MA, US, is currently a Founder and CEO at RephImmune Biotechnology. Ming-Wei Chen brings experience from previous roles at 自僱, Novartis Institutes for BioMedical Research (NIBR) and Novartis. Ming-Wei Chen holds a 2010 - 2014 Postdoc @ Rockefeller University. With a robust skill set that includes Gene Therapy, Molecular Biology, Biochemistry, Vaccines, Gene Transfer and more. Ming-Wei Chen has 1 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.